A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to Cambridge researchers.
In a trial where cancers were treated with chemotherapy followed by a targeted cancer drug before surgery, 100% of patients survived the critical three-year period post-surgery.
The discovery, published today in Nature Communications, could become the most effective treatment to date for patients with early-stage breast cancer with…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply